Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,596 | -99,729 | -64,652 | -30,301 | -67,254 |
| Depreciation Amortization | 205 | 82 | 39 | 19 | 52 |
| Accounts payable and accrued liabilities | 1,569 | 2,263 | 1,635 | 1,991 | 1,069 |
| Other Working Capital | 7,020 | 9,751 | 5,281 | 1,693 | 5,042 |
| Other Operating Activity | 16,654 | 11,531 | 8,077 | 2,143 | 8,945 |
| Operating Cash Flow | $-100,148 | $-76,102 | $-49,620 | $-24,455 | $-52,146 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,710 | -2,377 | -888 | -40 | -142 |
| Purchase Of Investment | -49,508 | -44,583 | -42,576 | -41,526 | -372,477 |
| Sale Of Investment | 182,831 | 134,331 | 95,138 | 45,040 | 90,928 |
| Investing Cash Flow | $130,613 | $87,371 | $51,674 | $3,474 | $-281,691 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 729 | 729 | 665 | 481 | 214,944 |
| Financing Cash Flow | $729 | $729 | $665 | $481 | $214,944 |
| Beginning Cash Position | 35,828 | 35,828 | 35,828 | 35,828 | 154,721 |
| End Cash Position | 67,022 | 47,826 | 38,547 | 15,328 | 35,828 |
| Net Cash Flow | $31,194 | $11,998 | $2,719 | $-20,500 | $-118,893 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,148 | -76,102 | -49,620 | -24,455 | -52,146 |
| Capital Expenditure | -2,710 | -2,377 | -888 | -40 | -142 |
| Free Cash Flow | -102,858 | -78,479 | -50,508 | -24,495 | -52,288 |